New CEO and New Company Name for Vicore Pharma AB

New CEO and New Company Name for Vicore Pharma AB Vicore Pharma AB has appointed Ann-Christin Kvarnström as its new CEO. The company has also changed its name to Vicore Pharma from Pharmacore AB. The reason for the name change is that possible confusion could arise with an American firm of a similar name. Ann-Christin (Anci) Kvarnström has a master's degree in Pharmacy from the University of Uppsala. She has worked for over twenty years in various positions at Astra and AstraZeneca, most recently as Vice President for Manufacturing Strategy located in the U.K. She has long experience in the development and manufacture of pharmaceutical products based on research. "We are very happy with the recruitment of Anci Kvarnström. She will bring valuable knowledge and experience to our team. Her organisational skills will be of great value when Vicore Pharma now enters a new phase in its development, says Thomas Hammargren, Chairman of the Board. Vicore Pharma AB is a research company developing a new group of pharmaceuticals for the treatment of common illnesses, such as functional gastrointestinal disorders and cardiovascular illnesses like high blood pressure and heart failure. The company recently received SEK 45 million from its principal owners to secure funding of the development programme. Uppsala August 29, 2002 More information can be provided by: Tomas Hammargren, +46 706-49 45 49 or tomas.hammargren@vicorepharma.com Ann-Christin Kvarnström, +46 739 60 62 00 or anci.kvarnstrom@vicorepharma.com Vicore Pharma is a research company with the objective to develop new medicines based on research in medicinal chemistry at Uppsala University and in the gastrointestinal and cardiovascular fields at the Sahlgrenska Academy, Göteborg University. High degree of patent protection, very qualified expertise in pharmaceutical chemistry and a considerable market potential characterise the enterprise. The company was founded in 2000. The principal owners are A + Science Invest, InnovationsKapital and Swedestart (CapMan AB). ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/08/29/20020829BIT00990/wkr0001.doc http://www.waymaker.net/bitonline/2002/08/29/20020829BIT00990/wkr0002.pdf

About Us

InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences - dynamic sectors that are rapidly expanding and where Nordic research plays an important role.